Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase IV/II Open-label Study to Evaluate Prompt Response to Treatment With Cisplatin, Gemcitabine and Bevacizumab in Patients With Non-small Lung Cancer.

NCT02316327 is registered in ClinicalTrials.gov with Fundacion Clinic per a la Recerca Biomédica as lead sponsor.

NCT NCT02316327
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02316327 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase IV/II Open-label Study to Evaluate Prompt Response to Treatment With Cisplatin, Gemcitabine and Bevacizumab in Patients With Non-small Lung Cancer.
Lead sponsor
Fundacion Clinic per a la Recerca Biomédica
Phase
Phase 4
Overall status
Completed
Start date
July 31, 2013
Completion date
October 31, 2016
Enrollment
19 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

non-small cell lung cancer (nsclc)